CONMED Corporation (CNMD) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

CONMED Corporation (CNMD)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

67.55

-1.95 (-2.81%)

At close: Jan 14, 2025, 3:59 PM

67.79

0.36%

After-hours Jan 14, 2025, 04:10 PM EST

undefined% (undefined)

Bid	63
Market Cap	2.09B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	4.22
PE Ratio (ttm)	16.01
Forward PE	n/a
Analyst	Buy

Ask	70.86
Volume	377,526
Avg. Volume (20D)	403,760
Open	69.69
Previous Close	69.50
Day's Range	66.04 - 70.05
52-Week Range	61.05 - 111.10
Beta	undefined

About CNMD

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide unique clinical solutions to orthopedic surgeons for the repair of soft tissue injuries, as well as suppor...

[Show more]

Industry Medical - Devices

Sector Healthcare

IPO Date Jul 23, 1987

Employees 4,000

Stock Exchange NYSE

Ticker Symbol CNMD

Website https://www.conmed.com

Analyst Forecast

According to 5 analyst ratings, the average rating for CNMD stock is "Buy." The 12-month stock price forecast is $75.5, which is an increase of 11.77% from the latest price.

Buy 80.00%

Hold 20.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

CONMED Corporation is scheduled to release its earnings on Feb 5, 2025, after market closes.
Analysts project revenue of $340.99M, reflecting a 4.26% YoY growth and earnings per share of 1.21, making a 14.15% increase YoY.

Why Price Moved

5 months ago · Source

-5.36%

CONMED shares are trading lower after the company ... Unlock content with Pro Subscription

8 months ago · Source

-11.58%

CONMED shares are trading lower after the company reported Q1 financial results. Needham, Piper Sandler and Wells Fargo lowered their respective price targets on the stock.

News

1 week ago · zacks.com

Should Value Investors Buy CONMED (CNMD) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 week ago · businesswire.com

CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2024 after the market close on Wednesday, February 5, 2025. T...

1 week ago · businesswire.com

CONMED Corporation to Present at the J.P. Morgan Healthcare Conference

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Finan...

1 week ago · zacks.com

CNMD vs. ALGN: Which Stock Is the Better Value Option?

Investors interested in Medical - Dental Supplies stocks are likely familiar with Conmed (CNMD) and Align Technology (ALGN). But which of these two stocks presents investors with the better value oppo...

2 weeks ago · zacks.com

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

CNMD is poised for growth on the back of strong product offerings and recurring revenues but faces headwinds from regulatory challenges, supply-chain constraints and cybersecurity risks.

1 month ago · zacks.com

Here's Why Conmed (CNMD) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 month ago · zacks.com

Here's Why Conmed (CNMD) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 month ago · zacks.com

Why Conmed (CNMD) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 month ago · businesswire.com

CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial ...

2 months ago · zacks.com

Conmed (CNMD) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 months ago · zacks.com

Why Conmed (CNMD) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

2 months ago · zacks.com

CONMED Beats on Q3 Earnings, Misses on Sales, Lowers '24 Sales View

CNMD's Q3 earnings beat estimates on the back of higher revenues and lower costs and expenses.

2 months ago · seekingalpha.com

CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript

CONMED Corporation (NYSE:CNMD ) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET Company Participants Curt Hartman – Chairman, President and Chief Executive Officer Pat Beyer – Chief Opera...

2 months ago · zacks.com

Conmed (CNMD) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Conmed (CNMD) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estim...

2 months ago · zacks.com

Conmed (CNMD) Surpasses Q3 Earnings Estimates

Conmed (CNMD) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $0.90 per share a year ago.

2 months ago · businesswire.com

CONMED Corporation Announces Third Quarter 2024 Financial Results

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Sales of $316.7 million in...

2 months ago · businesswire.com

CONMED Corporation Announces Leadership Succession

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman will retire as President and Chief Executive Officer (CEO) of the Company, effective January 1, 2025....

2 months ago · zacks.com

Conmed (CNMD) Earnings Expected to Grow: Should You Buy?

Conmed (CNMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.